|
|
Volumn 32, Issue 4, 2002, Pages 499-506
|
|
Where next in basic asthma research?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALLERGEN;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
IMMUNOGLOBULIN E;
INTERLEUKIN 13;
INTERLEUKIN 4;
INTERLEUKIN 5;
ARTICLE;
ASTHMA;
ATOPY;
BCG VACCINATION;
BRONCHUS HYPERREACTIVITY;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
ENVIRONMENTAL FACTOR;
FINANCIAL MANAGEMENT;
FOLLOW UP;
GENETIC ANALYSIS;
GENETIC POLYMORPHISM;
HEALTH CARE COST;
HUMAN;
IMMUNITY;
IMMUNOMODULATION;
IMMUNOTHERAPY;
LONGITUDINAL STUDY;
MEDICAL GENETICS;
MEDICAL RESEARCH;
NETHERLANDS;
NEUTROPHIL CHEMOTAXIS;
NONHUMAN;
PHARMACOGENETICS;
PHENOTYPE;
POLLUTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RHINITIS;
RISK ASSESSMENT;
RISK FACTOR;
T LYMPHOCYTE ACTIVATION;
T LYMPHOCYTE SUBPOPULATION;
TH1 CELL;
TH2 CELL;
ALLERGY AND IMMUNOLOGY;
ASTHMA;
ENVIRONMENTAL EXPOSURE;
HUMANS;
INDUSTRY;
INFLAMMATION;
ORGANIZATIONAL OBJECTIVES;
RESEARCH;
RESEARCH SUPPORT;
UNIVERSITIES;
|
|
EID: 0036228779
PISSN: 09547894
EISSN: None
Source Type: Journal
DOI: 10.1046/j.0954-7894.2002.01367.x Document Type: Article |
|
Times cited : (2)
|
|
References (2)
|
